The kinase LRRK2 is a risk factor for inflammatory bowel disease. New data show that LRRK2 blocks the transport of NFAT to the nucleus and that LRRK2 deficiency results in enhanced susceptibility to experimental colitis in mice.
References
Khor, B., Gardet, A. & Xavier, R.J. Nature 474, 307–317 (2011).
Barrett, J.C. et al. Nat. Genet. 40, 955–962 (2008).
Franke, A. et al. Nat. Genet. 42, 1118–1125 (2010).
Liu, Z. et al. Nat. Immunol. 12, 1063–1070 (2011).
Müller, M.R. & Rao, A. Nat. Rev. Immunol. 10, 645–656 (2010).
Willingham, A.T. et al. Science 309, 1570–1573 (2005).
Sharma, S. et al. Proc. Natl. Acad. Sci. USA 108, 11381–11386 (2011).
Gardet, A. et al. J. Immunol. 185, 5577–5585 (2010).
Barreiro, L.B. & Quintana-Murci, L. Nat. Rev. Genet. 11, 17–30 (2010).
Danoy, P. et al. PLoS Genet. 6, e1001195 (2010).
Ponting, C.P., Oliver, P.L. & Reik, W. Cell 136, 629–641 (2009).
Bartel, D.P. Cell 136, 215–233 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Jabri, B., Barreiro, L. Don't move: LRRK2 arrests NFAT in the cytoplasm. Nat Immunol 12, 1029–1030 (2011). https://doi.org/10.1038/ni.2139
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2139
- Springer Nature America, Inc.
This article is cited by
-
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
npj Parkinson's Disease (2021)
-
Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na+/K+ ATPase Activity in Dendritic Cells
Scientific Reports (2017)